Express Pharma

US FDA lifts hold on Covaxin’s clinical trials

The FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a temporary pause in dosing participants of the jab, following the WHO's observations on Covaxin-manufacturing plants in India

0 497